[Lys5, MeLeu9, Nle10]Neurokinin A (4-10)

[Lys5, MeLeu9, Nle10]Neurokinin A (4-10) (LMN-NKA), an analogue of Neurokinin A, is a selective and potent NK2R agonist. [Lys5, MeLeu9, Nle10]Neurokinin A (4-10) has prokinetic activity. [Lys5, MeLeu9, Nle10]Neurokinin A (4-10) can be used to study the roles of the NK-2 receptor in smooth muscle contraction in numerous tissues[1][2][3].

Product Specifications

CAS Number

[149270-28-0]

Product Name Alternative

LMN-NKA

UNSPSC

12352209

Target

Neurokinin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/lys5-meleu9-nle10-neurokinin-a-4-10.html

Purity

99.83

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

OC(C[C@H](N)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](C(C)C)C(NCC(N(C)[C@@H](CC(C)C)C(N[C@H](C(O)=O)CCCC)=O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)=O

Molecular Formula

C39H64N8O10

Molecular Weight

804.97

References & Citations

[1]Rupniak NMJ, et al. Prokinetic effects of the neurokinin NK2 receptor agonist [Lys5, MeLeu9, Nle10]-NKA (4-10) on bladder and colorectal activity in minipigs. Neuropeptides. 2019 Oct;77:101956. |[2]Rupniak NMJ, et al. [Lys5, MeLeu9, Nle10]-NKA (4-10) Elicits NK2 Receptor-Mediated Micturition and Defecation, and NK1 Receptor-Mediated Emesis and Hypotension, in Conscious Dogs. J Pharmacol Exp Ther. 2018 Jul;366 (1) :136-144. |[3]Sara Good, et al. [Lys5, MeLeu9, Nle10]NKA-4-10. Reference Module in Biomedical Sciences. 2019.